Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Wan

Showing results (181-190 of 217) with videos related to

Pageof 22
Sort By:
Clinical Neurology and Neurosurgery|May 9, 2024
Outcomes after deep brain stimulation for elderly versus non-elderly patients with Parkinson's diseaseYilong Zheng, Li Wei, Samantha Ya Lyn Ang, et al.
Investigational New Drugs|February 2, 2019
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trialJian-Chun Duan, Zhi-Jie Wang, Lin Lin, et al.
World Journal of Gastroenterology|June 16, 2015
Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survivalHui-Lin Ye, Dou-Dou Li, Qing Lin, et al.
Molecular Medicine Reports|July 1, 2016
GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytesJia Wan, Peng Li, Dong-Wei Liu, et al.
Journal for Immunotherapy of Cancer|December 11, 2020
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinomaHua Bai, Jianchun Duan, Chengcheng Li, et al.
Med (New York, N.Y.)|May 23, 2024
Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancerJie Zhao, Lu Wang, Anda Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 25, 2025
Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung CancersKailun Fei, Jie Zhao, Jiachen Xu, et al.
Ebiomedicine|February 11, 2026
Phenotypic age acceleration and early-onset lung cancer: a case-control and prognostic cohort study involving multiple clinical centres with validation in the UK BiobankRuolin Gao, Yuxuan Liao, Qiwen Zheng, et al.
Nutrition and Cancer|August 20, 2024
Association Between Sarcopenia, Clinical Outcomes, and Survival in Patients with Extensive-Stage Small Cell Lung Cancer Treated with First-Line Immunochemotherapy: A Prospective Cohort StudyLe Tian, Jia-Xin Huang, Rui Wan, et al.
Annals of the Academy of Medicine, Singapore|September 4, 2024
Long-term outcomes of subthalamic nucleus deep brain stimulation for Parkinson's disease in SingaporeYi Zhan Cai, Yilong Zheng, Wei Li, et al.
Pageof 22

Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
Clinical Neurology and Neurosurgery|May 9, 2024
Outcomes after deep brain stimulation for elderly versus non-elderly patients with Parkinson's diseaseYilong Zheng, Li Wei, Samantha Ya Lyn Ang, et al.
Investigational New Drugs|February 2, 2019
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trialJian-Chun Duan, Zhi-Jie Wang, Lin Lin, et al.
World Journal of Gastroenterology|June 16, 2015
Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survivalHui-Lin Ye, Dou-Dou Li, Qing Lin, et al.
Molecular Medicine Reports|July 1, 2016
GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytesJia Wan, Peng Li, Dong-Wei Liu, et al.
Journal for Immunotherapy of Cancer|December 11, 2020
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinomaHua Bai, Jianchun Duan, Chengcheng Li, et al.
Med (New York, N.Y.)|May 23, 2024
Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancerJie Zhao, Lu Wang, Anda Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 25, 2025
Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung CancersKailun Fei, Jie Zhao, Jiachen Xu, et al.
Ebiomedicine|February 11, 2026
Phenotypic age acceleration and early-onset lung cancer: a case-control and prognostic cohort study involving multiple clinical centres with validation in the UK BiobankRuolin Gao, Yuxuan Liao, Qiwen Zheng, et al.
Nutrition and Cancer|August 20, 2024
Association Between Sarcopenia, Clinical Outcomes, and Survival in Patients with Extensive-Stage Small Cell Lung Cancer Treated with First-Line Immunochemotherapy: A Prospective Cohort StudyLe Tian, Jia-Xin Huang, Rui Wan, et al.
Annals of the Academy of Medicine, Singapore|September 4, 2024
Long-term outcomes of subthalamic nucleus deep brain stimulation for Parkinson's disease in SingaporeYi Zhan Cai, Yilong Zheng, Wei Li, et al.
Pageof 22